NWIPB OpenIR
Design, preparation and characterization of cyclic RGDfK peptide modified poly(ethylene glycol)-block-poly(lactic acid) micelle for targeted delivery
Li, Caixia1,2; Wang, Wenlong1; Xi, Yuewei1; Wang, Jiexin1; Chen, Jian-Feng1; Yun, Jimmy3; Le, Yuan1
2016-07-01
发表期刊MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
卷号64页码:303-309
文章类型Article
摘要Molecular targeted cancer therapy is a promising strategy to overcome the lack of specificity of anticancer drug. While the binding of c(RGDfX) (cyclic Arginine-Glycine-Aspartic acid-Phenylalanine-Lysine) to alpha v beta(3) over expressed on tumor cell has been validated, the underlying interaction remains poorly understood. In this work, docking calculation was applied to investigate the interactions between c(RGDfX)/c(RGDfX)-PEG and alpha v beta(3). The calculated results indicated that c(RGDfK) interacted with alpha v beta(3) mainly by electrostatic interaction, stabilization interaction, and hydrophobic interaction. Conjugation of PEG chain to the c(RGDfX) weakened the binding affinity of c(RGDfK) to alpha v beta(3). Accordingly, docetaxel(DTX)-loaded target micelles (c(RGDfX)-PEG-PLA/PEG-PLA/DTX) were designed, characterized and evaluated using HeLa cells. In vitro release studies demonstrated both target and non-target micelles displayed almost the same profiles, which best fit in Ritger-Peppas model. Cellular uptake and MTT studies revealed that the target micelles with the presence of c(RGDfK) were more efficiently taken up by HeLa cells and significantly improved the cytotoxicity compared to that of non-target micelles. Cell inhibition rate of target micelles was improved by 20% after 24 h. Our findings suggest that target micelles may be a potential anticancer drug delivery system in the treatment of integrin alpha v beta(3) over-expressed on tumor cell. (C) 2016 Elsevier B.V. All rights reserved.
关键词Target Drug Delivery Rgdfk Peptide Nano-micelle Docking Calculations
WOS标题词Science & Technology ; Technology
DOI10.1016/j.msec.2016.03.062
关键词[WOS]INTEGRIN ALPHA(V)BETA(3) ; EXTRACELLULAR SEGMENT ; TUMOR ANGIOGENESIS ; CRYSTAL-STRUCTURE ; ALPHA-V-BETA-3 ; RELEASE ; ANTAGONISTS ; DOCKING ; COMPLEX ; CELLS
收录类别SCI
语种英语
项目资助者National Basic Research Program(2015CB932100) ; Program for New Century Excellent Talents University of China(NCET-12-0760) ; National "863" Program of China(2013AA032201)
WOS研究方向Materials Science
WOS类目Materials Science, Biomaterials
WOS记录号WOS:000376547700036
引用统计
被引频次:24[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://210.75.249.4/handle/363003/5758
专题中国科学院西北高原生物研究所
作者单位1.Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China
2.Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Tibetan Med Res, Xining 810001, Qinghai, Peoples R China
3.Univ New S Wales, Sch Chem Sci & Engn, Sydney, NSW 2052, Australia
推荐引用方式
GB/T 7714
Li, Caixia,Wang, Wenlong,Xi, Yuewei,et al. Design, preparation and characterization of cyclic RGDfK peptide modified poly(ethylene glycol)-block-poly(lactic acid) micelle for targeted delivery[J]. MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS,2016,64:303-309.
APA Li, Caixia.,Wang, Wenlong.,Xi, Yuewei.,Wang, Jiexin.,Chen, Jian-Feng.,...&Le, Yuan.(2016).Design, preparation and characterization of cyclic RGDfK peptide modified poly(ethylene glycol)-block-poly(lactic acid) micelle for targeted delivery.MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS,64,303-309.
MLA Li, Caixia,et al."Design, preparation and characterization of cyclic RGDfK peptide modified poly(ethylene glycol)-block-poly(lactic acid) micelle for targeted delivery".MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS 64(2016):303-309.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Caixia]的文章
[Wang, Wenlong]的文章
[Xi, Yuewei]的文章
百度学术
百度学术中相似的文章
[Li, Caixia]的文章
[Wang, Wenlong]的文章
[Xi, Yuewei]的文章
必应学术
必应学术中相似的文章
[Li, Caixia]的文章
[Wang, Wenlong]的文章
[Xi, Yuewei]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。